Pratteln, Switzerland, December 20, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that the Department of Health of Hong Kong, China, has approved AGAMREE® (vamorolone) for use in patients aged ...

Cytokinetics, Inc.(CYTK), a late-stage, specialty cardiovascular biopharmaceutical company, Friday announced that French drug major ...

The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 480.21% and ...

Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

“Current cash backing likely sits around $20 million but considering cash burn and trial close-out costs we see Percheron ...

Omeros reports that narsoplimab has not raised any notable safety issues across all clinical studies. For the treatment of TA ...

An international research team has developed a new therapy based on nanotechnology called nanoGLA for the treatment of Fabry ...

How are emerging plasma biomarkers related to the diagnostic tests currently used in clinical routines? And does the earlier ...

During an interview with the family, it was revealed that the infant’s father had been using 5% topical minoxidil to treat ...